Molecular formula: | C23H27N3O3 |
Average mass: | 393.487 |
Monoisotopic mass: | 393.205242 |
ChemSpider ID: | 4278 |
1H-Isoindole-1,3(2H)-dione, 2-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-
[ACD/Index Name]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)isoindoline-1,3-dione
2-{4-[4-(2-Methoxyphenyl)-1-piperazinyl]butyl}-1H-isoindol-1,3(2H)-dion
[German]
[ACD/IUPAC Name]2-{4-[4-(2-Methoxyphenyl)-1-piperazinyl]butyl}-1H-isoindole-1,3(2H)-dione
[ACD/IUPAC Name]2-{4-[4-(2-Méthoxyphényl)-1-pipérazinyl]butyl}-1H-isoindole-1,3(2H)-dione
[French]
[ACD/IUPAC Name]2-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl}-1H-isoindole-1,3(2H)-dione
1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine
1-(2-Methoxyphenyl)-4-(4-phthalimidobutyl)piperazine
1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine
102392-05-2
[RN]114627-30-4
[RN]115338-32-4
[RN]115388-32-4
[RN]1H-ISOINDOLE-1,3(2H)-DIONE,2-[4-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]BUTYL]-
2-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]isoindole-1,3-dione
2-Pyrrol4-[4-(2-methoxy-phenyl)-piperazin-1-yl]-butylmorpho-isoindole-1,3-dione
2-{4-[4-(2-Methoxy-phenyl)-piperazin-1-yl]-butyl}-isoindole-1,3-dione
2-{4-[4-(2-methoxyphenyl)piperazinyl]butyl}benzo[c]azolidine-1,3-dione
5-hydroxytryptamine receptor 1A
5-hydroxytryptamine receptor 1B
5-hydroxytryptamine receptor 1D
5-hydroxytryptamine receptor 1F
5-hydroxytryptamine receptor 2A
5-hydroxytryptamine receptor 2C
5-hydroxytryptamine receptor 3A
5-hydroxytryptamine receptor 7
5HT1A_HUMAN
5HT1A_RAT
5HT1B_RAT
5HT1F_HUMAN
5HT2A_RAT
5HT2C_RAT
5HT3A_MOUSE
5HT3A_RAT
5HT7R_HUMAN
5HT7R_RAT
A0A1V4J3K6_PATFA
A0A1V4J4E5_PATFA
A0A1V4J7Y5_PATFA
A0A1V4JDN9_PATFA
A0A1V4JMG2_PATFA
A0A1V4KJJ8_PATFA
A0A1V4KRM0_PATFA
A0A1V4KYG9_PATFA
A0A218UVI3_9PASE
D(1A) dopamine receptor
D(2) dopamine receptor
D(3) dopamine receptor
DRD1_HUMAN
DRD2_HUMAN
DRD3_HUMAN
G7ZKZ7_PIG
MFCD00877790
[MDL number]N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-phthalimide
N-γ-glutamylcysteine ethyl ester
NOCAS_43813
α-1A adrenergic receptor